| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2453 |
| Trial ID | NCT04544592 |
| Disease | B-Cell Non-Hodgkin's Lymphoma | B-Cell Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Generation | 2nd |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL |
| Year | 2020 |
| Country | United States |
| Company sponsor | University of Colorado, Denver |
| Other ID(s) | 18-2424.cc|P30CA046934 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||
|
|||||||